
Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy
- Author
- Robin Demuynck (UGent) , Yanou Engelen (UGent) , Andre Skirtach (UGent) , Stefaan De Smedt (UGent) , Ine Lentacker (UGent) and Dmitri Krysko (UGent)
- Organization
- Project
-
- Harnessing tumor acidosis and immunogenic ferroptosis for an innovative treatment of peritoneal carcinomatosis with PUFA-loaded nanovesicles
- High intensity focused ultrasound and mRNA nanomedicines: a new strategy to induce and boost anti-tumor immunity
- Controlled delivery of connexin43 mimetic peptide by nanocontainers for therapy of systemic inflammation
- Mechanobiology control of immunogenic cell death by bio-polymers for cancer therapy
- Triple punch against melanoma: photodynamic therapy, immunogenic cell death and photothermal ablation
- Novel photosensitizers to push the limits of photodynamic cancer therapy
- IIMMUNO—FER—GUARD: Immunotherapy-based Modality Using Dendritic cells Loaded with FERroptotic cancer Lysates - Guarding against Glioblastoma and Melanoma
- The impact of tumour vasculature on the immunogenicity of ferroptosis in tumour spheroids.
- Abstract
- Immunogenic cell death (ICD) is emerging as a key component of antitumor therapy that harnesses the immune system of the patient to combat cancer. In recent years, several efforts were made to improve the ICD-based therapies. Here, we discuss how nanomaterial-based strategies increase the efficacy of ICD and highlight their benefits and challenges.
- Keywords
- DAMPs, anticancer immunity, apoptosis, necroptosis, pyroptosis and ferroptosis nanoparticles, immunogenic cell death, nanomedicine, nanoparticles, nanocapsules, anticancer therapy, cancer, CANCER
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 427.88 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01J06C8SQNA973BC9XA18051AA
- MLA
- Demuynck, Robin, et al. “Nanomedicine to Aid Immunogenic Cell Death (ICD)-Based Anticancer Therapy.” TRENDS IN CANCER, vol. 10, no. 6, 2024, pp. 486–89, doi:10.1016/j.trecan.2024.03.003.
- APA
- Demuynck, R., Engelen, Y., Skirtach, A., De Smedt, S., Lentacker, I., & Krysko, D. (2024). Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy. TRENDS IN CANCER, 10(6), 486–489. https://doi.org/10.1016/j.trecan.2024.03.003
- Chicago author-date
- Demuynck, Robin, Yanou Engelen, Andre Skirtach, Stefaan De Smedt, Ine Lentacker, and Dmitri Krysko. 2024. “Nanomedicine to Aid Immunogenic Cell Death (ICD)-Based Anticancer Therapy.” TRENDS IN CANCER 10 (6): 486–89. https://doi.org/10.1016/j.trecan.2024.03.003.
- Chicago author-date (all authors)
- Demuynck, Robin, Yanou Engelen, Andre Skirtach, Stefaan De Smedt, Ine Lentacker, and Dmitri Krysko. 2024. “Nanomedicine to Aid Immunogenic Cell Death (ICD)-Based Anticancer Therapy.” TRENDS IN CANCER 10 (6): 486–489. doi:10.1016/j.trecan.2024.03.003.
- Vancouver
- 1.Demuynck R, Engelen Y, Skirtach A, De Smedt S, Lentacker I, Krysko D. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy. TRENDS IN CANCER. 2024;10(6):486–9.
- IEEE
- [1]R. Demuynck, Y. Engelen, A. Skirtach, S. De Smedt, I. Lentacker, and D. Krysko, “Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy,” TRENDS IN CANCER, vol. 10, no. 6, pp. 486–489, 2024.
@article{01J06C8SQNA973BC9XA18051AA, abstract = {{Immunogenic cell death (ICD) is emerging as a key component of antitumor therapy that harnesses the immune system of the patient to combat cancer. In recent years, several efforts were made to improve the ICD-based therapies. Here, we discuss how nanomaterial-based strategies increase the efficacy of ICD and highlight their benefits and challenges.}}, author = {{Demuynck, Robin and Engelen, Yanou and Skirtach, Andre and De Smedt, Stefaan and Lentacker, Ine and Krysko, Dmitri}}, issn = {{2405-8025}}, journal = {{TRENDS IN CANCER}}, keywords = {{DAMPs,anticancer immunity,apoptosis,necroptosis,pyroptosis and ferroptosis nanoparticles,immunogenic cell death,nanomedicine,nanoparticles,nanocapsules,anticancer therapy,cancer,CANCER}}, language = {{eng}}, number = {{6}}, pages = {{486--489}}, title = {{Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy}}, url = {{http://doi.org/10.1016/j.trecan.2024.03.003}}, volume = {{10}}, year = {{2024}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: